C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2336805
The invention relates to the use, particularly in gene therapy, of an NAB1 or NAB2 polypeptide or a biologically active fragment thereof, and to nucleic acid molecules encoding such polypeptides, in the manufacture of a medicament for the treatment of cell proliferation disorders associated with wound healing in a mammal, including human.
La présente invention concerne l'utilisation, en particulier en thérapie génique, d'un polypeptide ou d'un fragment biologiquement actif de NAB1 ou de NAB2, et des molécules d'acides nucléiques qui codent pour de tels polypeptides, dans la fabrication d'un médicament destiné au traitement des troubles de la prolifération cellulaire associés à une cicatrisation chez un mammifère, y compris chez l'homme.
Braddock Martin
Campbell Callum Jeffrey
Glaxo Group Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Pharmaceutical uses of nab1 and nab2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical uses of nab1 and nab2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical uses of nab1 and nab2 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1883542